Badeanlou et al. reported that genetic deletion of PAR2 or tissue factor (TF), which mediates coagulation factor VIIa-induced PAR2 activation, protected mice from developing obesity and insulin resistance when subjected to an HFD [15]. This evidence concerns the gene F2RL1 and obesity due to melanocortin 4 receptor deficiency.